Ireland: Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Home Support Providers Act Signed Into Law

The Health (Amendment) (Home Support Providers) Act 2026 (Act) was signed into law by the President on 1 July 2026. Although enacted, the Act has not yet been commenced, and will come into operation on dates appointed...

Ireland Healthcare

WF

William Fry

Life Sciences Outlook 2026

Arthur Cox's Life Sciences Outlook 2026 examines critical regulatory developments and strategic opportunities shaping Ireland's life sciences sector. The publication explores Ireland's EU Council Presidency and its potential impact on advancing key legislative initiatives including the Biotech Act I and medical device reforms. Industry leaders will find comprehensive analysis spanning pharmaceutical compliance, medtech regulation, data governance, M&A activity, and environmental considerations.

Ireland Healthcare

AC

Arthur Cox

Life Sciences Outlook 2026 - Medtech Regulatory And Compliance

The European Commission's December 2025 Health Package proposes significant amendments to the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR), responding to persistent industry calls for reform.

Ireland Healthcare

AC

Arthur Cox

Bridging The Gap: An Insight Into Europe’s Biotech Proposals

The European Commission has released a detailed Staff Working Document outlining the evidential basis for the European Biotech Act, revealing how the EU plans to address its biotechnology innovation...

European Union Healthcare

AC

Arthur Cox

European Medicines Agency SME Status – A Quick Guide

Ireland Healthcare

AC

Arthur Cox

Life Sciences And Healthcare M&A 2025: A Year In Review

Ireland Healthcare

AC

Arthur Cox

Assisted Decision-Making: New Act Ensures Certainty Ahead Of Deadline

Ireland Healthcare

AC

Arthur Cox

Pricing And Reimbursement Of Medicines In Ireland: New Framework Agreement 2026-2029 Published

Ireland Healthcare

AC

Arthur Cox

MDR/IVDR: Overview Of The Commission’s December 2025 Proposed Amendments

Ireland Healthcare

AC

Arthur Cox

Movement On The Pharma Package: Formal Adoption Within Reach

Ireland Healthcare

AC

Arthur Cox

Life Sciences: Update On National Strategy; Framework Agreements On Pricing And Supply Of Medicines

Ireland Healthcare

MF

McCann Fitzgerald

Clinical Trials Regulation In Ireland And The EU: Key Updates Shaping 2025 And 2026

European Union Healthcare

AC

Arthur Cox

Residential Healthcare – Who Pays Rates?

Ireland Healthcare

AC

Arthur Cox

Spill The Beans – New Information Powers For The Agri-Food Regulator

Ireland Healthcare

MF

McCann Fitzgerald

A Deep Dive Into The Regulation Of Artificial Intelligence Bill 2026

Ireland Commercial

M

Matheson

Authorisation Processes In Ireland (Podcast)

Ireland Finance

AC

Arthur Cox

Arbitration And Business Decision (Video)

Ireland Litigation

Aceris Law

Beyond The Black Box: Defensibility And Validation In Gen AI (Video)

Ireland Media & IT

AC

Arthur Cox

The EU Platform Work Directive (Video)

Ireland Employment

AC

Arthur Cox

See more

Food and Drugs Law

Life Sciences Outlook 2026

Arthur Cox's Life Sciences Outlook 2026 examines critical regulatory developments and strategic opportunities shaping Ireland's life sciences sector. The publication explores Ireland's EU Council Presidency and its potential impact on advancing key legislative initiatives including the Biotech Act I and medical device reforms. Industry leaders will find comprehensive analysis spanning pharmaceutical compliance, medtech regulation, data governance, M&A activity, and environmental considerations.

Ireland Healthcare

AC

Arthur Cox

Life Sciences Outlook 2026 - Mergers And Acquisitions (Video)

Explore how modern workplace design and professional environments are evolving to meet contemporary business needs. Discover insights into creating functional, aesthetically pleasing spaces that enhance productivity and reflect organizational values.

Ireland Strategy

AC

Arthur Cox

Pro = Active? CJEU Asked To Decide

HGF operates a comprehensive network of intellectual property offices spanning major cities across the United Kingdom, Europe, and Ireland.

HL

HGF Ltd

MDR/IVDR: Overview Of The Commission’s December 2025 Proposed Amendments

Ireland Healthcare

AC

Arthur Cox

Proposed EU-wide Restriction PFAS: Consultation To Be Held

Ireland Environment

M

Matheson

Clinical Trials Regulation In Ireland And The EU: Key Updates Shaping 2025 And 2026

European Union Healthcare

AC

Arthur Cox

The EU Platform Work Directive: What It Is And Why It Matters

Ireland Employment

AC

Arthur Cox

Spill The Beans – New Information Powers For The Agri-Food Regulator

Ireland Healthcare

MF

McCann Fitzgerald

EU Critical Medicines Act: What Life Sciences Companies Need To Know

Ireland Healthcare

MF

McCann Fitzgerald

See more

Life Sciences, Biotechnology & Nanotechnology

Life Sciences Outlook 2026

Arthur Cox's Life Sciences Outlook 2026 examines critical regulatory developments and strategic opportunities shaping Ireland's life sciences sector. The publication explores Ireland's EU Council Presidency and its potential impact on advancing key legislative initiatives including the Biotech Act I and medical device reforms. Industry leaders will find comprehensive analysis spanning pharmaceutical compliance, medtech regulation, data governance, M&A activity, and environmental considerations.

Ireland Healthcare

AC

Arthur Cox

Life Sciences Outlook 2026 - Mergers And Acquisitions (Video)

Explore how modern workplace design and professional environments are evolving to meet contemporary business needs. Discover insights into creating functional, aesthetically pleasing spaces that enhance productivity and reflect organizational values.

Ireland Strategy

AC

Arthur Cox

Life Sciences Outlook 2026 - Pharma Regulatory And Compliance

The EU continues its ambitious reform agenda for life sciences regulation, with landmark agreements on pharmaceutical legislation and biotech innovation frameworks. Ireland's Council Presidency is set to drive progress on critical medicines legislation and medical device reforms, while new investment initiatives aim to mobilize billions into Europe's biotech sector.

European Union Government

AC

Arthur Cox

Life Sciences Outlook 2026 - Data And Digital

European Union Government

AC

Arthur Cox

Bridging The Gap: An Insight Into Europe’s Biotech Proposals

European Union Healthcare

AC

Arthur Cox

European Medicines Agency SME Status – A Quick Guide

Ireland Healthcare

AC

Arthur Cox

EU AI Act Omnibus Deal Reached: Postponed Deadlines, Watermarking Compromise, And The Nudificiation Prohibition

Ireland Technology

WF

William Fry

Life Sciences And Healthcare M&A 2025: A Year In Review

Ireland Healthcare

AC

Arthur Cox

NIS 2 – A New Era For The Life Sciences Sector

Ireland Technology

M

Matheson

See more

Healthcare

Home Support Providers Act Signed Into Law

The Health (Amendment) (Home Support Providers) Act 2026 (Act) was signed into law by the President on 1 July 2026. Although enacted, the Act has not yet been commenced, and will come into operation on dates appointed...

Ireland Healthcare

WF

William Fry

Life Sciences Outlook 2026 - Medtech Regulatory And Compliance

The European Commission's December 2025 Health Package proposes significant amendments to the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR), responding to persistent industry calls for reform.

Ireland Healthcare

AC

Arthur Cox

European Medicines Agency SME Status – A Quick Guide

The European Medicines Agency offers special status to micro, small and medium-sized enterprises developing medicines, providing financial incentives, translation services, and regulatory guidance to foster innovation. Companies meeting specific employee and financial thresholds can access fee reductions, deferred payments, and expert support through the EMA's SME office.

Ireland Healthcare

AC

Arthur Cox

When Does The Clock Start? Key Takeaways From The CJEU’s Recent Sanofi Pasteur Judgment

Ireland Litigation

MF

McCann Fitzgerald

Life Sciences And Healthcare M&A 2025: A Year In Review

Ireland Healthcare

AC

Arthur Cox

Assisted Decision-Making: New Act Ensures Certainty Ahead Of Deadline

Ireland Healthcare

AC

Arthur Cox

Pricing And Reimbursement Of Medicines In Ireland: New Framework Agreement 2026-2029 Published

Ireland Healthcare

AC

Arthur Cox

MDR/IVDR: Overview Of The Commission’s December 2025 Proposed Amendments

Ireland Healthcare

AC

Arthur Cox

Urban Wastewater Treatment Directive – Irish Transposition

Ireland Environment

M

Matheson

See more

Latest Videos

See more

What Regulatory Challenges Are Facing The Life Sciences Sector? (Video)

WF

William Fry

Launch Of Our Medical Device Publication (Video)

WF

William Fry

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More